- Home
- KUKE vs PYPD Comparison
KUKE vs PYPD Comparison
Compare KUKE & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KUKE
- PYPD
- Stock Information
- Founded
- KUKE 2002
- PYPD 2008
- Country
- KUKE China
- PYPD Israel
- Employees
- KUKE N/A
- PYPD N/A
- Industry
- KUKE Other Consumer Services
- PYPD Medical/Dental Instruments
- Sector
- KUKE Real Estate
- PYPD Health Care
- Exchange
- KUKE Nasdaq
- PYPD Nasdaq
- Market Cap
- KUKE 21.2M
- PYPD 24.2M
- IPO Year
- KUKE 2021
- PYPD 2020
- Fundamental
- Price
- KUKE $0.40
- PYPD $3.56
- Analyst Decision
- KUKE
- PYPD Strong Buy
- Analyst Count
- KUKE 0
- PYPD 2
- Target Price
- KUKE N/A
- PYPD $12.00
- AVG Volume (30 Days)
- KUKE 1.1M
- PYPD 8.1K
- Earning Date
- KUKE 12-26-2024
- PYPD 11-13-2024
- Dividend Yield
- KUKE N/A
- PYPD N/A
- EPS Growth
- KUKE N/A
- PYPD N/A
- EPS
- KUKE N/A
- PYPD N/A
- Revenue
- KUKE $14,784,158.00
- PYPD N/A
- Revenue This Year
- KUKE N/A
- PYPD N/A
- Revenue Next Year
- KUKE N/A
- PYPD N/A
- P/E Ratio
- KUKE N/A
- PYPD N/A
- Revenue Growth
- KUKE 10.48
- PYPD N/A
- 52 Week Low
- KUKE $0.33
- PYPD $2.95
- 52 Week High
- KUKE $4.07
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- KUKE 37.88
- PYPD 54.93
- Support Level
- KUKE $0.38
- PYPD $3.30
- Resistance Level
- KUKE $0.54
- PYPD $3.59
- Average True Range (ATR)
- KUKE 0.12
- PYPD 0.21
- MACD
- KUKE -0.01
- PYPD 0.02
- Stochastic Oscillator
- KUKE 10.75
- PYPD 68.27
About KUKE Kuke Music Holding Limited
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.